Chemotherapy is one of the most effective treatments for a wide range of cancers, but it comes with an often-traumatic side effect: hair loss. Patients who experience hair loss lose hair all over their bodies, but it typically regrows after treatment ceases.
However, one popular chemotherapy drug is linked to permanent hair loss. Taxotere was approved by the U.S. Food and Drug Administration in 1996 to treat cancers of the head, neck, stomach, prostate, and lungs. A 2013 U.K. study found that up to 15 percent of women who took Taxotere to treat their cancers experienced permanent hair loss.
Sanofi-Aventis, Taxotere’s manufacturer, issued a warning concerning permanent hair loss—or irreversible alopecia—on the labels of the medication in the European Union and Canada beginning in 2005. But the warning wasn’t added to Taxotere packaging and labels in the U.S. until several years later, putting thousands of patients at risk for permanent hair loss.
Did You Experience Permanent Hair Loss? You Deserve Compensation.
Being diagnosed with cancer and undergoing the often-debilitating treatment process can be stressful and traumatic. Side effects such as nausea and hair loss only make it more difficult for patients, but for some, the latter is permanent—leading to anxiety, reduced self-esteem, and depression.
At Richard Harris Personal Injury Law Firm, we believe that anyone who suffered permanent hair loss after taking Taxotere should be fairly compensated. If you or someone you love experienced irreversible alopecia due to Taxotere usage, call us today for a free consultation.